24 results
Cholestatic Liver Disease: Primary Biliary Cirrhosis vs Primary Sclerosing Cholangitis

#pathophysiology #pbc #psc #hepatology #comparison
Primary Biliary Cirrhosis ... Cholangitis #pathophysiology ... #pbc #psc #hepatology ... #comparison
Primary Biliary Cirrhosis - Pathophysiology
Environmental Risk Factors: Geographic location, Smoking, Microbial triggers, Xenobiotics, Nail polish
Epigentics Risk
Primary Biliary Cirrhosis ... Environmental Risk ... polish Epigentics Risk ... methylation Genetic Risk ... #hepatology
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding risk ... #Diagnosis #Hematology ... CHADS2VASc #HASBLED #Comparison ... #Score #Risk #Stroke
Cirrhosis Risk / Staging Calculators

BONACINI CIRRHOSIS DISCRIMINANT SCORE (CDS)
CHILD PUGH CLASSIFICATION OF SEVERITY OF CIRRHOSIS 

#Cirrhosis
Cirrhosis Risk / ... OF SEVERITY OF CIRRHOSIS ... #Cirrhosis ... #ESLD #hepatology ... #risk #staging
NAFLD / NASH Progression Timeline
Healthy Liver → NAFLD/NASH → 0.25-3.2%/year → Cirrhotic NASH → 0.3-2.6%/year →
0.25-3.2%/year → Cirrhotic ... • NAFLD/NASH → Cirrhotic ... NASH Risk Factors ... NASH → HCC Risk ... Progression #Timeline #hepatology
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
scores for stroke risk ... and bleed risk ... dL) 1 Liver (cirrhosis ... #Score #Risk #Stroke ... AFib #Diagnosis #Hematology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
diagnosis and risk-stratification ... • Risks: infection ... Management #treatment #hematology ... #oncology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
transfused patientsl • Risk ... blood donor • Pathophysiology ... transfused patients • Risk ... Transfusion #Reactions #hematology ... #diagnosis #comparison
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... Anticoagulation #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
patients at high risk ... interactions and bleeding risk ... also balance the risk ... Anticoagulation #Management #Hematology ... #Oncology